The role of glycopeptides in the treatment of intravascular catheter-related infections

Clin Microbiol Infect. 2002 May;8(5):310-5. doi: 10.1046/j.1469-0691.2002.00468.x.

Abstract

There is increasing concern over multiresistant staphylococcci in catheter-associated infections. Local infections due to coagulase-negative staphylococci are usually resolved by removal of the intravascular catheter. However, if the device should remain for a certain period of time, e.g. to complete a course of chemotherapy, the antibiotic lock technique with a glycopeptide should be considered. In case of septic embolism to the lung caused by a multiresistant Staphylococccus aureus or Enterococcus faecium, systemic therapy with glycopeptides, streptogramins or linezolid must be employed.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use*
  • Catheterization, Central Venous / adverse effects*
  • Cross Infection / drug therapy*
  • Endocarditis / therapy
  • Female
  • Glycopeptides*
  • Humans
  • Kidney Failure, Chronic / therapy
  • Male
  • Middle Aged
  • Pulmonary Embolism / drug therapy
  • Sepsis / drug therapy
  • Short Bowel Syndrome / metabolism
  • Staphylococcal Infections / drug therapy*
  • Staphylococcus aureus / growth & development

Substances

  • Anti-Bacterial Agents
  • Glycopeptides